Food animals and antimicrobials: impacts on human health
BM Marshall, SB Levy - Clinical microbiology reviews, 2011 - Am Soc Microbiol
Antimicrobials are valuable therapeutics whose efficacy is seriously compromised by the
emergence and spread of antimicrobial resistance. The provision of antibiotics to food animals …
emergence and spread of antimicrobial resistance. The provision of antibiotics to food animals …
[HTML][HTML] Antibacterial resistance worldwide: causes, challenges and responses
SB Levy, B Marshall - Nature medicine, 2004 - nature.com
The optimism of the early period of antimicrobial discovery has been tempered by the
emergence of bacterial strains with resistance to these therapeutics. Today, clinically important …
emergence of bacterial strains with resistance to these therapeutics. Today, clinically important …
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell …
…, GR Hudes, Y Park, SH Liou, B Marshall… - Journal of clinical …, 2004 - ascopubs.org
Purpose To evaluate the efficacy, safety, and pharmacokinetics of multiple doses of CCI-779,
a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced …
a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced …
[PDF][PDF] Commensals: underappreciated reservoir of antibiotic resistance
BM Marshall, DJ Ochieng, SB Levy - Microbe, 2009 - josedeondarza.com
A ntibiotic resistance, reported for sulfonamides in the mid-1930s and for penicillins in the
1940s, remains a stubborn quandary. What was once confined mainly to hospitals …
1940s, remains a stubborn quandary. What was once confined mainly to hospitals …
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer
…, MS Pollack, JP Boni, G Dukart, B Marshall… - Clinical cancer …, 2006 - AACR
Purpose: Patients with advanced cancer received temsirolimus (Torisel, CCI-779), a novel
inhibitor of mammalian target of rapamycin, iv once daily for 5 days every 2 weeks to …
inhibitor of mammalian target of rapamycin, iv once daily for 5 days every 2 weeks to …
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
…, DE Griffith, EG Scerpella, B Marshall - Journal of …, 2014 - academic.oup.com
Objectives We report the largest clinical experience using tigecycline-containing regimens for
salvage treatment of patients with Mycobacterium abscessus and Mycobacterium chelonae…
salvage treatment of patients with Mycobacterium abscessus and Mycobacterium chelonae…
Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma
NC Twine, JA Stover, B Marshall, G Dukart, M Hidalgo… - Cancer research, 2003 - AACR
Expression profiling has demonstrated that transcriptomes of primary malignancies differ
from those in normal tissue. It is unknown, however, whether there exist “surrogate” …
from those in normal tissue. It is unknown, however, whether there exist “surrogate” …
Inter-and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage.
B Marshall, D Petrowski… - Proceedings of the …, 1990 - National Acad Sciences
The spread of wild-type Escherichia coli bearing a transferable plasmid was studied in a
farm environment. E. coli of bovine and porcine origin were marked by resistance to nalidixic …
farm environment. E. coli of bovine and porcine origin were marked by resistance to nalidixic …
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma
ME Burczynski, NC Twine, G Dukart, B Marshall… - Clinical cancer …, 2005 - AACR
Purpose: Given their accessibility, surrogate tissues, such as peripheral blood mononuclear
cells (PBMC), may provide potential predictive biomarkers in clinical pharmacogenomic …
cells (PBMC), may provide potential predictive biomarkers in clinical pharmacogenomic …
Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu
JL Walson, B Marshall, BM Pokhrel… - The Journal of …, 2001 - academic.oup.com
Within Nepal, geographic, social, and economic barriers greatly limit access to allopathic
health care. The country therefore offered the opportunity to evaluate the effect of antibiotic …
health care. The country therefore offered the opportunity to evaluate the effect of antibiotic …